Glutamine--from conditionally essential to totally dispensable?

Area of Science:

• Critical Care Medicine
• Nutritional Science
• Clinical Trials

Background:

• A recent multicenter trial reported harm from glutamine supplementation in critically ill patients, contradicting numerous studies showing benefits or no effect.
• The discrepancy in outcomes, particularly the emergence of harm, necessitates further investigation into the underlying mechanisms.

Purpose of the Study:

• To analyze the reasons behind the conflicting results of glutamine supplementation in critically ill patients.
• To investigate whether the route of administration (enteral vs. parenteral) influences the effects of glutamine supplementation.

Main Methods:

• Review and meta-analysis of existing studies on glutamine supplementation in critically ill patients.
• Comparison of outcomes based on different administration routes: parenteral nutrition (PN), enteral nutrition (EN), or combined routes.

Main Results:

• The meta-analysis suggests that harm observed in a recent trial may be associated with intravenous administration of glutamine via parenteral nutrition or combined nutrition.
• This contrasts with studies where glutamine was administered enterally, which reported beneficial or neutral effects.

Conclusions:

• Explaining clinical trial discrepancies solely through meta-analysis may not fully elucidate underlying biological mechanisms.
• Further research is crucial to understand the mechanistic basis for glutamine's effects and to determine optimal supplementation strategies for critically ill patients receiving parenteral nutrition.